Salute e Benessere

GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year…

Lille (France), Cambridge (Massachusetts, USA), Zurich (Switzerland), April 25, 2024 - GENFIT (Nasdaq and Euronext: GNFT),a late-stage biopharmaceutical company committed to improving the lives of patients with rare, life-threatening liver diseases, today announced the publication of its 2024 Extra-Financial Performance Report (fiscal year 2023). Third edition of the Extra-Financial Performance report Since 2022, GENFIT has published a detailed Extra-Financial Performance report in...

Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar…

CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA ®CAMBRIDGE, Mass., April25, 2024(GLOBE NEWSWIRE) --BiogenInc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA ®1. The intravenous...

Abzena Launches EpiScreen® 2.0, a Next Generation Immunogenicity Tool for…

Using flow cytometry, EpiScreen® 2.0's Time Course Assay delivers levels of sensitivity comparable to traditional assays using [3H]-thymidine as a readout for proliferation and allows characterization of the responding immune cells by multiplexing the readout with cell activation markers. Beyond the standard assessment of CD4+ T cells, the platform can evaluate the responses of other immune cells, including CD8+ T-cells, giving insight into the MoA, which can be useful for gene therapy…

Rise in Healthcare Expenditure Boosting the Investment of the US Medical…

The U.S. Medical Bathtubs Market The U.S. Medical Bathtubs Market Home healthcare services are gaining momentum, and medical electrical bathtubs are becoming essential equipment in home care settings, ensuring the provision of hygienic and comfortable bathing experiences for patients in the comfort of their homes. The demand for the medical bathtubs market is rising due to multiple factors, including the increasing prevalence of chronic diseases, the rising geriatric population, and...

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world…

CARBIOS celebrates the groundbreaking of its PET biorecycling plant, a world first, with its partnersCARBIOS' first plant is also a world first using revolutionary enzymatic depolymerization technology, marking a major step forward in the transition to a circular economy for plastic and textilesMore than 200 guests were present to mark this important occasion: representatives of institutions, partner brands and industrial partnersThe plant will have a capacity of 50kt/year of...

Oxurion Receives Transparency Notification from Atlas Special Opportunities…

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – April 25, 2024 – 07:00 PM CET(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on April 25, 2024, from Atlas Special Opportunities, LLC indicating that as of April 19, 2024, it held...

Guerbet : Q1 2024 revenue.

Q1 2024 revenue Quarterly activityRevenue: €194.3m, up 8.8% at CER 1 Growth remains particularly strong in Asia (+26.8% at CER) and the Americas (+20.1% at CER); the EMEA region (-6.2% at CER) was temporarily impacted by the reform of the supply of contrast products in FranceAnnual targets confirmedRevenue: expected growth of over 8% like-for-like and at CERProfitability: restated EBITDA margin rate 2higher than in 2021 (14.4%) Villepinte, 25 April 2024, 5...

ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO

The company's Board of Directors has appointedPieter Kroeseas the new Chief Executive Officer effectiveApril 25, 2024. Pieter takes the role after serving as COO of ScreenPoint for over five years. During that time, he has managed the transition of the company from an early startup to a thriving enterprise with hundreds of customers using ScreenPoint's flagship Transpara software to support millions of scans a year. "I am thrilled to lead ScreenPoint into its next phase of...

Biomarkers Market Worth $93.8 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43 Browse in-depth TOC on "Biomarkers Market" 699 - Tables 53 - Figures 520 - Pages Biomarkers Market Scope: The consumables segment accounted for the largest share by product & service segment in the biomarkers market in 2023. By product & service, the biomarkers market...

Varian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced…

"We have chosen Halcyon for our medical center because it offers a streamlined workflow, making treatment faster and more efficient. Additionally, its unique design creates a spacious and comfortable treatment environment, while precision targeting minimizes exposure to healthy tissues, helping to lead to improved outcomes" stated Dr Hossam Alassaf, Chief Executive Officer, emphasizing that "the system's versatility accommodates diverse patient needs. We believe that Halcyon will…

Control Valve Market worth $13.0 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Control Valve Market" 130 – Tables70 – Figures230 – Pages Browse in-depth TOC on "Control Valve Market" 130 – Tables 70 – Figures 230 – Pages Control Valve Market Report Scope: Actuator Component to hold the largest market share in the year 2023. The Actuator in Control Valve sector is witnessing significant expansion, fueled by rising industrial automation demands and the necessity for precise regulation across diverse domains like oil & gas,...

BioInnovation Institute & Science announce the launch of the Translational…

The introduction of the Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine recognizes researchers who have developed innovative advances with translational potential to impact women's health and gender medicine globally. The introduction of the Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine recognizes researchers who have developed innovative advances with translational potential to impact women's health and gender medicine…

Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple…

Tarun Singhal, MBBS, M.D., Director of PET Imaging Program in Neurologic Diseases at Brigham and Women's Hospital, a founding member of Mass General Brigham Healthcare System, and Associate Professor of Neurology at Harvard Medical School, stated, “Last week at the American Academy of Neurology annual meeting, we presented, for the first time, quantitative [F18]PBR06-PET data showing the dampening of microglial activation, an indicator of brain inflammation, in patients with non-active...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities…

ORION CORPORATIONSTOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS 25 APRIL 2024 at 16.30 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 24 April 2024...

Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply

Steffen Saltofte: "Our participation in the Alliance underscores our commitment. Together, we need to ensure that essential medicines are accessible to all people who depend on them. As generic medicines represent 70% of treatment volume in Europe and constitute 9 out of 10 products on the critical medicines list, our role is crucial in maintaining the continuity of healthcare services across the continent." Steffen Saltofte: "Our participation in the Alliance underscores our…

AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029

Recently, Avant Technologies Inc. (OTC:AVAI) strengthened its AI-powered healthcare offerings by acquiring Wired-4-Health, a company specializing in healthcare technology and data services. This addition supports Avant's goal to create the first supercomputing network in the country. This network will offer big data and AI software companies a quicker, more potent, and more affordable computing infrastructure. Recently,Avant Technologies Inc. (OTC:AVAI)strengthened its AI-powered healthcare...

Olight Marks 17th Anniversary with Autism Awareness Charity Sale, Raises…

The decision to direct the anniversary celebration towards charitable causes underscores Olight's dedication to spreading positivity and making meaningful impacts beyond the field of outdoor lighting, while emphasizing gratitude for support and collective impact on autism research. The decision to direct the anniversary celebration towards charitable causes underscores Olight's dedication to spreading positivity and making meaningful impacts beyond the field of outdoor lighting, while...

Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for…

The MFDS approval of JAQBO is based on comprehensive results including the Phase III clinical trial across 28 sites in Korea. The study demonstrated JAQBO's effectiveness on erosive esophagitis, with a healing rate of 97.9% after 8 weeks of treatment. These results were presented at the United European Gastroenterology Week in October 2023. The MFDS approval of JAQBO is based on comprehensive results including the Phase III clinical trial across 28 sites in Korea. The study demonstrated…

Multivitamin Melt Market to Reach US$ 1,614.7 Million by 2034 Amid Rising Demand…

Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19527 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19527 High demand for multivitamin melts is mainly due to consumers lacking essential nutrients amid busy lifestyles and increasing processing of foods. Consumers are easily maintaining dietary gaps by adding...

Digital Personalized Nutrition Market 2024 Exclusive Report with Accurate…

Digital personalized nutrition describes the practice of using electronic resources to create unique plans for each person's diet and nutritional needs. The global digital personalized nutrition market is anticipated to have significant expansion in the coming years, propelled by technological progress. Biomarker analysis, microbiome analysis, and DNA sequencing in saliva, blood, and urine are all examples of diagnostic tools formed by these technical advancements. The expansion of wearable…

Nexstim Plc: Managers' Transactions, Hildén

Company Announcement, Helsinki, 25 April 2024 at 1:15 PM (EEST) Nexstim Plc: Managers' Transactions, Hildén Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers' transactions as follows:Person subject to the notification requirement Name: Timo Hildén Position: Member of the Board/Deputy member Issuer: Nexstim Oyj LEI: 743700S7ZI0LNMHZ6Y27 Notification type: INITIAL NOTIFICATION Reference number: 59502/4/4____________________________________________ Transaction…

Global Cleaning and Hygiene Product Market is set to surge at a CAGR of 6.3%…

Download the Sample PDF report to explore key market insights and trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-19534 Download the Sample PDF report to explore key market insights and trends:https://www.futuremarketinsights.com/reports/sample/rep-gb-19534 Compliance with safety, environmental, and labeling standards is important for market access and consumer trust. Evolving regulations regarding ingredient disclosure and sustainability drive innovation and...

PolyU forms global partnership with ZEISS Vision Care to expand impact and…

Furthermore, this partnership paves the way for a long-term collaboration in research and development between PolyU and ZEISS, focusing on myopia control and other ophthalmic technologies. The close relationship between PolyU and ZEISS started some years ago when both partners began to explore collaboration on research and education. Furthermore, this partnership paves the way for a long-term collaboration in research and development between PolyU and ZEISS, focusing on myopia control and…

Nexstim Plc: Managers' Transactions, Forss

Company Announcement, Helsinki, 25 April 2024 at 1:10 PM (EEST) Nexstim Plc: Managers' Transactions, Forss Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers' transactions as follows:Person subject to the notification requirement Name: Martin Forss Position: Member of the Board/Deputy member Issuer: Nexstim Oyj LEI: 743700S7ZI0LNMHZ6Y27 Notification type: INITIAL NOTIFICATION Reference number: 59500/5/4____________________________________________ Transaction…

Altri Comunicati